Followers | 0 |
Posts | 307 |
Boards Moderated | 0 |
Alias Born | 07/28/2020 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, October 09, 2020 8:33:33 AM
Ineffective by FDA in treating advanced LAPC.
THIS IS FACT.
If we are using statistical probabilities and associate the reduction of 4 tumors in patients from 20+ year old previous phase 2 foreign trial from Lohr’s study with cell encapsulation therapy then we must also attribute the treatment to the other 4 tumors who GREW in patients while receiving treatment.
There were literally 4 patient’s who’s tumors were reduced in size and 4 patients who’s tumors GREW. With median growth outweighing median reduction. This is what we call statistically insignificant data.
GO READ THE STUDY DON’T BELIEVE THE WEBSITE AND $40,000 video made to sell a penny stock not educate the public.
FDA does not even come close to considering this appropriate for phase 2 and probably won’t even let it go to phase 1. FDA might consider letting animal studies proceed, but I imagine this will be a total and complete failure.
1.) ACCORDING TO PMCB. This is a completely new manufactured product with many differences from 20+ year old treatment. Therefore, It cannot be used to determine efficacy of the new cells. PMCB is saying it’s new and trying to use old data from old method of cells. FDA doesn’t roll that WAY.
2.) not enough patients in both previous studies combined. The data suggests even with the small patient studies, that this treatment is not effective when compared to current treatments available in 2020.
3.) FDA doesn’t overlook reputation of a company. A poor reputation in the industry such as no prior biotech experience or impressions of a scam will cause them to spend more time evaluating and ultimately not allowing CTs to go forward especially if they believe it will not advance the CURRENT treatments either in place or in advanced CTs such as triple combination therapy and immune therapy alone.
4.) ITS ALREADY SOOOO OBVIOUS THIS IS A PUMP AND DUMP FROM THE CONSTANT VOLATILE market Schizophrenia such as STUTTGART’s market continually up 40% then down 50% the next day. All while any and all buying will ALWAYS BE MATCHED BY INSIDE SELLING
5.) the investor is trapped. Those hopeful won’t sell at a loss and left holding the bag. CEO knows this and relies on SH longs who will continue to hold allowing them to continue to introduce new NOVICE buyers while they continue to sell off EVERY last share they are vested in their salary package. It’s a modern day pump and dump that doesn’t die in a few years. It’s takes decades.
If anyone is lucky enough to get out with even a 50% loss then consider them the lucky ones. This company will continue to dive over time never again reaching even .015 again. CEO took a big gamble submitting something he knew would never make it to Phase 2b. It’s called FRAUD! ... did I mention the CEO is defendant to FRAUD in 2 separate cases in his home town of Orange County, Ca. Occourts.org. Spend the buck and look up the CEO of a public company. It’s your right.
Recent PMCB News
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 08:05:04 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 05/30/2024 08:05:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 08:40:20 PM
- PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease • Business Wire • 05/21/2024 01:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:38:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/06/2024 02:56:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/15/2023 10:25:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:00:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:02:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:01:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2023 10:00:10 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 11/22/2023 09:00:15 PM
- PharmaCyte Biotech Acquires $5 Million Stake in Emerging Women’s Health Innovator Femasys, Inc. • Business Wire • 11/15/2023 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:25:09 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- PharmaCyte Biotech Provides Corporate Update on Cell-in-a-Box Technology • Business Wire • 10/31/2023 01:15:00 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/21/2023 09:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 09/18/2023 10:04:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 09/15/2023 09:00:03 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 09/12/2023 01:56:25 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM